Xconomy Seattle

ISB Cuts Deal to Sequence 100 Genomes

Luke Timmerman11/2/09

The Seattle-based Institute for Systems Biology and Mountain View, CA-based Complete Genomics said today they are planning to gather full human genome sequences from 100 individuals to study Huntington’s disease. The experiment, the largest complete human genome disease association study ever conducted, will examine samples from patients with Huntington’s, family members, and matched controls to look for genomic differences linked to how the disease presents itself and progresses. Complete Genomics, which we profiled in August, is best known for its effort to sequence entire human genomes for $5,000 apiece, far cheaper than is currently possible with other technologies.

Luke Timmerman is the National Biotech Editor of Xconomy, and the Editor of Xconomy Seattle. E-mail him at ltimmerman@xconomy.com or follow him on Twitter at twitter.com/ldtimmerman.

Add Your Thoughts

You will have 10 minutes to edit your post after you press publish.

Comments may be edited for clarity and length, rejected, or deleted.
By clicking "Publish," you are agreeing to these Terms and Conditions.

    

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.

© 2007-2012, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Site produced by Andrew Koyfman with design from Rob Hunter.